Drug Interaction Report
1 potential interaction and/or warning found for the following 2 drugs:
- Aldara (imiquimod topical)
- verteporfin
Interactions between your drugs
imiquimod topical verteporfin
Applies to: Aldara (imiquimod topical), verteporfin
Using verteporfin together with imiquimod topical may cause an increase in photosensitivity reactions, which could cause your skin to burn when exposed to light. Check with your doctor to see if you should temporarily withhold any of your medications before and after treatment with verteporfin. You should avoid exposure of skin or eyes to sunlight or bright indoor lights (examination lamps, operating room lamps, tanning beds, lights at close proximity) for 5 days after treatment with verteporfin. If you must go outdoors in the daylight during this 5-day time frame it is important to protect your skin and eyes by wearing protective clothing and dark sunglasses, even if you cannot see the sun (e.G., cloudy day). Exposing your skin to normal indoor lighting is helpful as it will help your body get rid of verteporfin more quickly, so you do not need to stay inside in the dark. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
No alcohol/food interactions were found with the drugs in your list. However, this does not necessarily mean no food interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Voltaren Arthritis Pain Gel
Voltaren Arthritis Pain Gel (diclofenac topical) is used to treat joint pain in the hands, wrists ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Efudex
Efudex is used for actinic keratosis, basal cell carcinoma, keratosis, skin cancer
Pennsaid
Pennsaid (diclofenac sodium topical solution) is used to treat osteoarthritis of the knee. Includes ...
Libtayo
Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell ...
Tagamet HB
Tagamet HB is used for duodenal ulcer, duodenal ulcer prophylaxis, erosive esophagitis, GERD ...
Erivedge
Erivedge (vismodegib) is used to treat basal cell carcinoma that has spread to other parts of the ...
Aspercreme Arthritis Pain Relief Gel
Aspercreme Arthritis Pain Relief Gel is used for osteoarthritis, pain
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.